Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
APPROVED_FOR_MARKETING
Conditions studied: HIV Infections
In brief
To provide early access to tipranavir and evaluate the safety and tolerance of tipranavir combined with low dose of ritonavir in patients with progressive, HIV-1 disease who have failed or are intolerant to currently approved treatments for HIV infection, who are unable to participate in another tipranavir controlled clinical trial and have an urgent need for anti-HIV treatment.
Key facts
- Study ID
- NCT00062660
- Run by
- Boehringer Ingelheim
- Starts
- 2003-05-01
- Expected to finish
- 2014-04-01
- Last updated by the study team
- 2016-11-30
Who can join
Age: 2 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients aho have a positive serology HIV antibody test confirmed by Western blot, p24 antigen assay, HIV-1 RNA or HIV culture and are highly pre-treated and virus resistant to multiple protease inhibitors.
Where it is running
- 1182.58.29 — Los Angeles, California, United States
- 1182.58.34 Campus Code 696446 — Los Angeles, California, United States
- 1182.58.42 Synergy Hematology/Oncology — Los Angeles, California, United States
- 1182.58.43 — Los Angeles, California, United States
- 1182.58.03 — San Francisco, California, United States
- 1182.58.33 Kaiser Permanente Medical Center, Clinical Trials Unit — San Francisco, California, United States
- 1182.58.37 AIDS Health Care Foundation — Los Angeles, Connecticut, United States
- 1182.58.41 Circle Medical, LLC — Norwalk, Connecticut, United States
- 1182.58.28 — Washington D.C., District of Columbia, United States
- 1182.58.38 — Miami Beach, Florida, United States
- 1182.58.40 Drs. Raben and Feldman Research Associates — South Miami, Florida, United States
- 1182.58.23 Hillsborough County Health Department — Tampa, Florida, United States
- 1182.58.36 Suite 525 — Atlanta, Georgia, United States
- 1182.58.08 — Honolulu, Hawaii, United States
- 1182.58.22 — Chicago, Illinois, United States
- 1182.58.32 — New Orleans, Louisiana, United States
- 1182.58.15 — Boston, Massachusetts, United States
- 1182.58.19 Henry Ford Hospital — Detroit, Michigan, United States
- 1182.58.04 Kansas City Free Health Clinic — Kansas City, Missouri, United States
- 1182.58.25 Wohl Clinic — St Louis, Missouri, United States
- 1182.58.02 Wellness Center — Las Vegas, Nevada, United States
- 1182.58.09 Polari Medical Group — New York, New York, United States
- 1182.58.30 — Chapel Hill, North Carolina, United States
- 1182.58.06 University of Cincinnati Medical Center, Infectious diseases — Cincinnati, Ohio, United States
- 1182.58.31 — Scottsdale, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.